West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 332.77 USD 0.97% Market Closed
Market Cap: 24.1B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

32.2
Current
30.3
Median
18.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
32.2
=
Enterprise Value
23.7B USD
/
EBITDA
736.4m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
32.7
2-Years Forward
EV/EBITDA
28
3-Years Forward
EV/EBITDA
24.2

See Also

Discover More